Wellesta Healthcare Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 4.91 Cr
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 22.15%
- Profit Growth -54.25%
- Ebitda -66.64%
- Net Worth 42.75%
- Total Assets 92.41%
About Wellesta Healthcare
Wellesta Healthcare Private Limited (WHPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 19 August 2019 (Five years and five months 17 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamal Anand, Milan Paleja, Holger Kunze, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24304MH2019FTC329393
-
Company No.
329393
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
19 Aug 2019
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Wellesta Healthcare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Holger Kunze
|
Nominee Director | 26-Oct-2021 | Current |
Kamal Anand
|
Director | 19-Aug-2019 | Current |
Milan Paleja
|
Director | 19-Aug-2019 | Current |
|
Ashish Srivastava
|
Director | 23-Feb-2024 | Current |
Financial Performance of Wellesta Healthcare.
Wellesta Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.15% increase. The company also saw a substantial fall in profitability, with a 54.25% decrease in profit. The company's net worth Soared by an impressive increase of 42.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellesta Healthcare?
In 2023, Wellesta Healthcare had a promoter holding of 96.98% and a public holding of 3.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Intellimed Healthcare Solutions Private LimitedMilan Paleja, Holger Kunze and 1 more are mutual person
-
Arabian Petroleum LimitedMilan Paleja is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellesta Healthcare?
Wellesta Healthcare has a workforce of 207 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellesta Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellesta Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
